AEGiS-BBC: Many more receiving HIV therapy BBC News OnlineImportant note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
Click here to return to BBC News Online main menu
DonateNow
Print this article

Many more receiving HIV therapy

BBC News - September 30, 2009


Falling prices and increased testing have led to a marked rise in the number of people in the poorest parts of the world receiving treatment for HIV.

The number of people on antiretrovirals had risen by 1m by the end of 2008, a 36% increase from the previous year, the World Health Organisation reports.

But despite the progress, less than half of those needing treatment get it.

The majority of pregnant women still go untreated, and their infants are infected via "vertical transmission".

Nevertheless testing of pregnant women is continuing to rise in line with rates overall.

Testing is the gateway to treatment, and in many areas facilities providing this service increased by about 35%, noted the Towards Universal Access report which looked at 158 countries.

"An Aids free generation is no longer an impossibility - the elimination of vertical transmission is in sight," said Jimmy Kolker, head of the HIV/Aids division at UNICEF.

Just the same

Drug prices have also fallen by between 10% and 40% - the result of a combination of a factors, including greater co-operation by the pharmaceutical companies and the prevalence of generic drugs.

There is currently momentum behind the establishment of a patent pool, which would allow the creation of cheap copies of drugs and would be one way of getting newer and more effective second-line treatments into the developing world.

Quote: " Prevention services still fail to reach many in need " -- Margaret Chan WHO

The report highlighted the problems of access to these treatments: the majority of people who are being treated in the developing world receive a combination of cheaper, older drugs which are barely used in the West because of their sometimes serious side-effects.

Three years ago, the World Health Organisation recommended a shift away from these medications to less toxic ones based on either Zidovudine or Tenofovir.

But these remain significantly pricier than the older ones: currently the Tenofovir-based combination is more than twice as expensive as the traditional combination.

Cash flow

But by current reckoning, at least 5m people with HIV do not have access to even the most basic treatment.

The pace of new infections also continues to outstrip the number treated: for every one person being put on a therapy regime, three people contract the disease.

The report highlighted particular concerns about access to high risk groups, such as gay men and sex workers. It noted that as many as 6m drug users are infected worldwide, but less than 40% are reached by HIV prevention programmes.

There are also concerns that recession will hit the international funds flowing into countries where the need is great.

"This report shows tremendous progress in the global HIV/Aids repsonse," said WHO director general Margaret Chan.

"But we need to do more. At least 5m people living with HIV still do not have access to life-prolonging treatment and care.

"Prevention services still fail to reach many in need. Governments and international partners must accelerate their efforts to achieve universal access to treatments."


090930
BB090914


Copyright © 2009 - BBC. Reproduction of this article (other than one copy for personal reference) must be cleared through the BBC.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.